| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5549892 | GENZYME | Enhanced in vivo uptake of glucocerebrosidase |
Aug, 2013
(10 years ago) | |
Cerezyme is owned by Genzyme.
Cerezyme contains Imiglucerase.
Cerezyme has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Cerezyme are:
- US5549892
Cerezyme was authorised for market use on 23 May, 1994.
Cerezyme is available in injectable;injection dosage forms.
Cerezyme can be used as method of treating a human subject having gaucher's disease.
The generics of Cerezyme are possible to be released after 27 August, 2013.
Drugs and Companies using IMIGLUCERASE ingredient
Market Authorisation Date: 23 May, 1994
Treatment: Method of treating a human subject having gaucher's disease
Dosage: INJECTABLE;INJECTION
More Information on Dosage
CEREZYME family patents
